Every day, we sift through the filings to spot where the real conviction lies β cutting through the noise to highlight the most meaningful insider moves.
π Celcuity $CELC β Baker Bros. Advisors increased its 13D stake from 17.11% to 19.99%.
The biotech-focused specialists continue to press their bet, adding on strength and pushing ownership close to 20%.
When the Baker Bros lean in like this, itβs worth paying attention.
π ARS Pharmaceuticals $SPRY β Millennium Management increased its 13G stake from 3.21% to 5.40%.
The multi-strategy fund crosses the key 5% threshold, building a meaningful position in the biotech name as shares continue to carve out a multi-year distribution range.
Hereβs The Hot Corner, with data from March 24, 2026:
π Banc of California $BANC β Millennium Management increased its 13G stake from 1.14% to 5.00%.
A notable addition in the regional bank space, with the fund stepping in as the group faces pressure, suggesting a longer-term view despite near-term weakness.
